EUPATI Guidance for Patient Involvement in Medicines Research and Development: Health Technology Assessment
The main aim of health technology assessment (HTA) is to inform decision making by health care policy makers. It is a systematic process that evaluates the use of health technologies and generally involves a critical review of international evidence related to clinical effectiveness of the health te...
Main Authors: | Amy Hunter, Karen Facey, Victoria Thomas, David Haerry, Kay Warner, Ingrid Klingmann, Matthew May, Wolf See |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-09-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fmed.2018.00231/full |
Similar Items
-
EUPATI Guidance for Patient Involvement in Medicines Research and Development (R&D); Guidance for Pharmaceutical Industry-Led Medicines R&D
by: Kay Warner, et al.
Published: (2018-10-01) -
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Regulatory Processes
by: David Haerry, et al.
Published: (2018-08-01) -
EUPATI and Patients in Medicines Research and Development: Guidance for Patient Involvement in Ethical Review of Clinical Trials
by: Ingrid Klingmann, et al.
Published: (2018-09-01) -
Editorial: The European Patients Academy on Therapeutic Innovation (EUPATI) Guidelines on Patient Involvement in Research and Development
by: Per Spindler, et al.
Published: (2018-11-01) -
The Launch of the European Patients' Academy on Therapeutic Innovation in the Netherlands: A Qualitative Multi-Stakeholder Analysis
by: Annemiek van Rensen, et al.
Published: (2020-09-01)